Pulling SEC filings + quote and writing the call…

RENASANT CORP
Next earnings Jul 20, 2026 · consensus $0.94 EPS, $287M rev
Last earnings -0.2% on 2026-04-28
Transformative First Bancshares merger inflates the balance sheet but dilutes EPS and ROE — fair value, wait for integration to prove out.
Diluted EPS $2.07 · FY2025
Middling fundamentals and a rich price (~63% above fair value) leave little margin of safety — a wait-and-see.
Renasant's FY2025 is a transformation year dominated by the April 1, 2025 merger with The First, which added $7.57B in assets, $5.17B in loans and $6.45B in deposits net of purchase accounting. The optics are jarring: total assets jumped 48.3% to $26.8B and share count rose 47.9% to 94.1M, while net income slipped 7.3% to $181M and diluted EPS collapsed 36.7% to $2.07. MD&A explicitly attributes the EPS drop to merger and conversion-related expenses (noninterest expense rose to $651.7M from $461.6M) and a $107.5M provision for credit losses versus just $9.3M in 2024, driven by the Day 1 CECL provision on acquired loans plus organic growth. Strip those out and adjusted diluted EPS is actually $3.06 vs. $2.76 in 2024 — meaningful underlying improvement.
The franchise quality looks intact. Net interest income surged to $804M from $512M, net interest margin expanded to 3.79% from 3.34%, and adjusted NIM widened to 3.57%. Capital is healthy at 14.52% shareholders' equity-to-assets and 9.26% tangible common equity-to-tangible assets. Management is returning capital — buying back 388,940 shares at $34.29 in Q4 (well below the current $43.29) and growing dividends 46.3% to $78.6M. The $60M subordinated note redemption in October signals balance-sheet confidence post-merger.
Is RNST a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $176M | $166M | $145M | $195M | $181M |
| Diluted EPS | $3.12 | $2.95 | $2.56 | $3.27 | $2.07 |
| Net margin | — | — | — | — | — |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Regulation FD investor materials disclosure; no operational change
Q1 2026 10-Q; first full quarter reflecting The First merger integration
Q1 2026 10-Q; first full quarter reflecting The First merger integration
Annual meeting results and bylaw amendments; routine governance
Regulation FD investor presentation; no new financials
Q1 2026 earnings released; first full post-merger quarter results
Annual proxy: director slate, exec comp and auditor ratification
Officer/director appointment or departure disclosed
Sources: SEC EDGAR (CIK 0000715072, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 6/25/2026, 1:06:23 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 9:06 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 3 sales
| 2026-05-29 | Engel Connie L Director | Sell | 1.26K @ $40.90 | $51.4K |
| 2026-05-19 | DALE ALBERT J III Director | Sell | 1.65K @ $39.80 | $65.7K |
| 2026-05-15 | MCGRAW EDWARD ROBINSON Director | Exercise | 1.04K @ $39.82 | $41.4K |
| 2026-05-15 | MCGRAW EDWARD ROBINSON Director | Tax | 385.00 @ $39.82 | $15.3K |
| 2026-05-14 | WAYCASTER C MITCHELL Executive Vice Chairman | Sell | 12.7K @ $39.50 | $502K |
| 2026-04-28 | CREEKMORE JOHN Director | Award | 2.06K | |
| 2026-04-28 | MCGRAW EDWARD ROBINSON Director | Award | 2.06K | |
| 2026-04-28 | Suggs Sean M. Director | Award | 2.06K |
| Fisher Asset Management | 318K sh | $11.5M |
As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median